Product Details

Toctino

Alitretinoin
30 mg
Capsule


DIN/PIN/NPN

02337649

Manufacturer

GlaxoSmithKline Inc., GlaxoSmithKline Consumer Health Care

Formulary Listing Date

2013-04-30  

Unit Price

NA

Amount MOH Pays

NA

Coverage Status

Not a Benefit

ODB Formulary Therapeutic Classification

Therapeutic Note

Alitretinoin: Alitretinoin should only be prescribed by physicians knowledgeable in the use of retinoids systemically, who understand the risk of teratogenicity in females of childbearing potential. Alitretinoin is contraindicated in pregnancy and females must not become pregnant while taking alitretinoin and for at least one month after its discontinuation. Please refer to the Toctino product monograph for details on use in women of childbearing potential.

ATC Code

D11AH04

Interchangeable Products

DIN/ PIN/ NPN Brand name Unit Price Amount MOH pays
02337649 Toctino NA NA
02477440 Hanzema 16.9868 16.9868
 

LU Clinical Criteria

NO  

EAP Criteria

NO

Product Monograph

View Monograph